In this report, we describe the effects of a brain-penetrant small molecule inhibitor of mutant IDH1 on in vitro and in vivo 2-HG production in mutant cell lines and patient-derived orthotopic glioma xenograft mouse models. Here, IDH1 is linked to central nervous system cancer.